An algorithm may help predict the risk of scoliosis in patients who have received disease-modifying SMA treatment, a study ...

Columnist Ari Anderson has set a goal for 2025: to multiply the chances of good things coming his way each time they happen.

Nearly 4 of every 5 infants in Italy born with SMA type 1 since the approval of disease-modifying therapies (DMTs) are alive, ...

Spinal muscular atrophy (SMA) is a genetic, progressive disease that affects the nervous system and muscles. The life expectancy for people with SMA depends on the type of their disease and symptom ...

Columnist Ari Anderson explains how light, both literal and figurative, plays an important role in helping him maintain his ...

Columnist Halsey Blocher, who lives with SMA, feels a sense of connection with a Christmas movie's depiction of a disabled princess.

Zolgensma was found in a real-world study to ease breathing difficulties in children with SMA and reduce respiratory-related ...

The SMA Europe project has patients sharing their story of how SMA treatment affects their lives with goal of better access ...

Swallowing function may have improved in spinal muscular atrophy (SMA) patients since disease-modifying therapies (DMT) have ...

Spinal muscular atrophy (SMA) is a rare genetic condition resulting in symptoms that most commonly include progressive muscle weakness and poor muscle tone. While motor function is typically most ...

Edward Smith, MD, is an adjunct professor of pediatrics at Duke University Hospital. He earned his medical degree from the University of Mississippi School of Medicine and has practiced since 2007. He ...

Type 4 is the mildest form of spinal muscular atrophy (SMA), a rare genetic disease that leads to muscle weakness and wasting. SMA is characterized by the progressive loss of motor neurons, the nerve ...